Moderna gets full US approval for COVID shot in at-risk children 6 months and older
Coronavirus,Coronavirus Vaccine,Vaccines,FDA
From the Center
AllSides Media Bias Rating: Center
The U.S. Food and Drug Administration has granted full approval for Moderna's (MRNA.O), opens new tab COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Headline Roundup
Newly Declassified Docs Accuse Fauci of Lying About COVID Origins, Research Funding
June 22nd, 2026
News
Mass Kidnappings, Covid Contingencies, ICE Controversies: Stories You May Have Missed
Malayna J. Bizier
June 18th, 2026
Red Blue Translator
Anti-vaxxer
Bias
Media Accused of Misleading, Sensationalizing Tesla ‘Autopilot’ Killing
Julie Mastrine
June 25th, 2026